Emine SÖNMEZ, Mohammed NAEM, Catherine TROISI, F. Blaine HOLLINGER, Hsiang Ju LIN

Detection of hepatitis C virus RNA by PCR in hemophiliac patients

Bu çalışmada hemofîlili hastaların serumlarında polimeraz zincir reaksiyonu (PCR) ile Hepatit C virıısıı (HCV) RNA 'sı bakıldı. Toplam 232 dondurulmuş serum (- 30°C'de) test edildi. 1.14 serumda (%49.13) HCV RNA pozitif bulundu, 114 serumda (% 49.13) HCV RNA negatif bulundu. 4 serum (%1.72) tanımlanamadı. [Turgut Özal Tıp Merkezi Dergisi 1996;3(4):294-298]

Hemofilili hastalarda hepatit C virüs RNA'sının PCR'la taranması

This study was performed for the detection of hepatitis C virus (HCV) RNA by polymerase chain reaction (PCR) in the sera of the hemophiliac patients. A total of 232'frozen (at -30°C) hemophiliac sera were examined. It was found that 114 of the patients (49.13%) had HCV RNA positive sera, 114 of the patients (49.13%) had HCV RNA negative sera and the sera of the 4 patients (1.72%) were considered as indetermined. [Journal of Turgut Özal Medical Center 1996;3(4):294-298]

PDF

___

1.Esteban R, Esteban JI, Lopez-Talavera JC, et al.Epidemiology of Hepatitis C virus infection. In HollingerFB, Lemon SN, Margolis H (eds). Viral Hepatitis and LiverDisease. Baltimore, Williams and Wilkins, 1991; 413- 4.
2.Houghton M, Richman K, Han J, et al. Hepatitis C virus: Arelative of the pestiviruses and flaviviruses. In Hollinger FB,Lemon SN, Margolis H, (eds). Viral hepatitis and Liverdisease. Baltimore,Williams and Wilkins, 1991; 323-33.
3.Hollinger FB, Lin HJ. Community-acquired hepatitis Cvirus infection (editorial). Gastroenterology 1992;102:1426-9.
4.Bukh J, Purcell RH, Miller RH. Importance of primerselection for the detection of hepatitis C virus RNA withpolymerase chain reaction assay. Proc Nat Acad Sci USA1992; 89: 187-91.
5.Cristiano K, Di Bisceglie AM, Hoofnagle JH, et al. HepatitisC viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reactionusing multiple primer sets. Hepatology 1991;14:51-5.
6.Farci P, Alter HJ, Wong D, et al. A long -term study ofhepatitis C virus replication in non-A, non-B hepatitis. NEng J Med 1991; 325:98-104.
7.Garson JA,Tedder RS, Briggs M, et al. Detection ofhepatitis C viral sequences in blood donations by ‘nested‘polymerase chain reaction and prediction of infectivity.Lancet 1990; 335: 1419-22.
8.Hsu HH, Wright TL, Luba D, et al. Failure to detecthepatitis C virus genome in human secretions with thepolymerse chain reaction. Hepatology, 1991;14:763-7.
9.Inchauspe G, abe K, Zebedee S, et al. Use of conservedsequences from hepatitis C virus for the detection of viralRNA in infected sera by the polymerase chain reaction.1991; 14: 595-600.
10.Okamato H, Okado S, Sugiyama Y, et al. Detection ofhepatitis C virus RNA by a two-stage polymerase chainreaction. Japan J Exp Med 1990; 60: 215-22.
11.Okamato H, Okado S, Sugiyama Y, et al. The 5’ terminalsequences of the hepatitis C virus genome. Japan J Exp Med1990; 60:167-77.
12.Weiner AJ, Kuo G, Bradley DW, et al. Detection of hepatitisC viral sequences in non-A, non-B hepatitis. Lancet 1990;335:1-3.
13.Lin HJ, Shi N, Mizokami M, et al. Polymerase chainreaction assay for hepatitis C virus using a single tube forreverse transcrioption and serial rounds of amplificationwith nested primer pairs. J Med Virol 1992; 38: 220-5.
14.Alter MI, Hadler SC, Judson FN. Risk factors for acute non-A, non-B hepatitis in the USA and association withhepatitis C virus infection JAMA 1990; 264: 231-5.
15.Fuchs K, Motz M, Scherier E, et al. Characterization ofnucleotide sequences from European hepatitis C virusisolates. Gene 1991; 103:163-9.
16.Han JH, Shyamala V, Richman KH, et al. Characterizationof the terminal regions of hepatitis C viral RNA:identification of conserved sequences in the 5’ untranslatedregion and poly (A) tails at the 3’ end. Proc Nat Acad SciUSA 1991; 1711-5.
17.Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloninigof the human hepatitis C virus genome from Japanesepatients with non-A, non-B hepatitis. Proc Nat Acad SciUSA 1990; 87: 9524-8.
18.Ogata N, Alter HJ, Miller RH, et al. Nucleotide sequencesand mutation rate of the H strain of hepatitis C virus. ProcNat Acad Sci USA. 1991; 88: 3392-6
19.Takamizawa A, Mori C, Fuke I, et al. Structure andorganization of the hepatitis C virus genome isolated fromhuman carriers. J Virol 1991; 1105-13.
20.Takeuchi K, Kubo Y, Boonmar S, et al. Putativenucleocapsid and envelope protein genes of hepatitis C virusdetermined by comparison of the nucleotide sequences ofhepatitis C virus determined by comparison of thenucleotide sequences of two isolates derived from andexperimentally infected chimpanze and healthy humancarriers. J General Virol 1990; 71: 3027-33.
21.Weiner AJ, Truett MA, Rosenblatt J, et al. HCV:immunologic and hybridization-based diagnostics. InHollinger FB, Lemon SM, Margolis HS (eds). ViralHepatitis and Liver Disease. Baltimore, Williams andWilkins 1991; 360-3.
22.Kwok S, Higuchi R. Avoiding false positives with PCR.Nature 1989; 339: 237-8.
23.Alter MJ, Mares A, Hadler SC, et al. The effect ofunderporting on the apperent incidence and epidemiolgy ofacute viral hepatitis. Am J Epidemiol 1987; 125:133-9.
24.Alter MJ. The detection, transmission, and outcome ofhepatitis C virus infection. Infect Agents and Dis 1993; 2:1551-66.
25.Feinman SV,Berris B, Bojarski S. Post-tranfusion hepatitisin Toronto, Canada. Gastroenterology 1988; 95: 464-9.
26.Esteban JI, Gonzalez A, Hernandez JM, et al. Evaluation ofantibodies to hepatitis C virus in a study of transfusion-associated hepatitis. New Eng J Med 1990; 323: 1107-12.
27.Colombo M, Oldani S, Donato MF, et al. A multicenter,prospective study of posttransfusion hepatitis in Milan.Hepatology 1987; 7:709-12.
28.Watanabe J, Minegishi K, Mitsumori T, et al. Prevalence ofanti-HCV antibody in blood donors in the Tokyo area. VoxSanguinis 1990; 59: 86-8.
29.Aach RD, Szumuness W, Mosley JW. Serum alanineaminotransferase of donors in relation to the risk pf non-A,non-B hepatitis in recipients: the transfusion-transmittedviruses study. N Eng J Med 1981; 340: 989-94.
30.Koziol DE, Hollan PV, Alling DW. Antibody to hepatitis Bcore antigen as a paradoxical marker for non-A, non-Bhepatitis agents in donated blood. Ann Intern Med 1986;488-95.
31.Choo QL, Kuo G, Winer AJ, et al. Isolation of a cDNAclone derived from blood-borne non-A, non-B viral hepatitisgenome. Science 1989; 244: 359-62.
32.Esteban JI, Genesca J, Alter HI. Hepatitis C: molecularbiology, pathogenesis, epidemiology, clinical features andprevention. In: Boyer JL, Ockner RK (eds). Progress inLiver Diseases, vol 10, Philadelphia, W.B. Saunders Co1992: 253-82.
33. Simmonds P, Zhang LQ, Watson HG, et al. Hepatitis Cquantification and sequences in blood productshemophiliacs and drug users. Lancet 1990;336:1469-72.
34.Ragni MV, Nidimbe OK, Rice EO, et al. The presence ofhepatitis C virus antibody in human immunodeficiencyvirus-positive hemofiliac men undergoing HCVseroconversion. Blood 1993; 82: 1010-5.
35.De Virgilis S, Lai ME, Argiolu F. A prosoective study onpost-transfusion non-A,non-B hepatitis in thalassemiachildren: prevalance of antibody to hepatitis C virus. In:Hollinger FB, Lemon SM, Margolis HS (eds). ViralHepatitis and Liver Diseae. Baltimore: Williams andWilkins, 1991:1220-5.
36.Markin M, Preston FE, Triger DR. hepatitis C antibody andchronic liver disease in haemophilia. Lancet 1990:1117-9.
37.Everhart JE, Di Biscelige AM, Murray LM. Risk for non-A,non-B (type C) hepatitis through sexual or hoshold withchronic carriers. Ann Intern Med 1990; 112: 544-5.
38.Nishioka K. Postransfusion hepatitis C. In: Proceedings,Second International Symposium on HCV, Los Angeles,1990; 36.
39.Arch RD, Cladd ES, Blaine-Hollinger F, Mosley JW,Peterson DA, Taylor PE, Johnson RG, Barbosa LH, NemoGJ. Hepatitis C virus infection in post-transfusion hepatitis.An analysis with first and second generation assays. N EngMed 1991; 325: 1325-9.
40.Yuki N, Hayashi N, Hagiwara H, et al. Blood screening forasymptomatic hepatitis C virus carriers with second-generation hepatitis C virus assays. In Nishioka K, SuzukiH, Mishioro S, Oda T, (eds). Viral Hepatitis and LiverDisease. Tokyo, Berlin, Heidelbeg, New York, SpringerVerlag 1994;352-4.<